31. Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort). Issue 3 (March 2022) Authors: Barré, Tangui; Fontaine, Hélène; Ramier, Clémence; Di Beo, Vincent; Pol, Stanislas; Carrieri, Patrizia; Marcellin, Fabienne; Cagnot, Carole; Dorival, Céline; Zucman-Rossi, Jessica; Zoulim, Fabien; Carrat, Fabrice; Protopopescu, Camelia Journal: Clinical nutrition Issue: Volume 41:Issue 3(2022) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Epidemiology update for HCV and HBV in ESRD in France: Still a lot to do. (June 2017) Authors: Parlati, Lucia; Laurain, Anne; Pol, Stanislas Journal: Liver international Issue: Volume 37:Number 6(2017) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Issue 4 (10th July 2018) Authors: Allaire, Manon; Nahon, Pierre; Layese, Richard; Bourcier, Valérie; Cagnot, Carole; Marcellin, Patrick; Guyader, Dominique; Pol, Stanislas; Larrey, Dominique; De Lédinghen, Victor; Ouzan, Denis; Zoulim, Fabien; Roulot, Dominique; Tran, Albert; Bronowicki, Jean‐Pierre; Zarski, Jean‐Pierre; Riachi, ... Journal: Hepatology Issue: Volume 68:Issue 4(2018) Page Start: 1245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Faldaprevir (Bi 201335), Deleobuvir (Bi 207127) and Ribavirin Oral Therapy for Treatment-Naive HCV Genotype 1: Sound-C1 Final Results. Issue 8 (November 2013) Authors: Zeuzem, Stefan; Asselah, Tarik; Angus, Peter; Zarski, Jean-Pierre; Larrey, Dominique; Müllhaupt, Beat; Gane, Ed; Schuchmann, Marcus; Lohse, Ansgar W; Pol, Stanislas; Bronowicki, Jean-Pierre; Roberts, Stuart; Arasteh, Keikawus; Zoulim, Fabien; Heim, Markus; Stern, Jerry O; Nehmiz, Gerhard; Kukolj,... Journal: Antiviral therapy Issue: Volume 18:Issue 8(2013) Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial12. Issue 6 (12th June 2013) Authors: Sulkowski, Mark S.; Bourlière, Marc; Bronowicki, Jean‐Pierre; Asselah, Tarik; Pawlotsky, Jean‐Michel; Shafran, Stephen D.; Pol, Stanislas; Mauss, Stefan; Larrey, Dominique; Datsenko, Yakov; Stern, Jerry O.; Kukolj, George; Scherer, Joseph; Nehmiz, Gerhard; Steinmann, Gerhard G.; Böcher, Wulf O. Journal: Hepatology Issue: Volume 57:Issue 6(2013:Jun.) Page Start: 2155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Genetic diversity of genotype 6 HCV infections in France: Epidemiology and consequences for treatment strategy. Issue 11 (29th July 2019) Authors: Pronier, Charlotte; Fontaine, Hélène; Dorival, Céline; Carrat, Fabrice; Pol, Stanislas; Thibault, Vincent Journal: Journal of viral hepatitis Issue: Volume 26:Issue 11(2019) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Issue 4 (30th January 2018) Authors: Poordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David; Hézode, Christophe; Felizarta, Franco; Reindollar, Robert W.; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih‐Wei; Lei, Yang; Ng, Teresa I.; Krishnan, Preethi; Kopecky‐Br... Journal: Hepatology Issue: Volume 67:Issue 4(2018) Page Start: 1253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study. Issue 10003 (17th October 2015) Authors: Roth, David; Nelson, David R; Bruchfeld, Annette; Liapakis, AnnMarie; Silva, Marcelo; Monsour, Howard; Martin, Paul; Pol, Stanislas; Londoño, Maria-Carlota; Hassanein, Tarek; Zamor, Philippe J; Zuckerman, Eli; Wan, Shuyan; Jackson, Beth; Nguyen, Bach-Yen; Robertson, Michael; Barr, Eliav; Wahl, Ja... Journal: Lancet Issue: Volume 386:Issue 10003(2015) Page Start: 1537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Grazoprevir/elbasvir combination therapy for HCV infection. (January 2017) Authors: Vallet-Pichard, Anaïs; Pol, Stanislas Journal: Therapeutic advances in gastroenterology Issue: Volume 10:Number 1(2017) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. HCV and the kidney. (January 2016) Authors: Corouge, Marion; Vallet‐Pichard, Anaïs; Pol, Stanislas Journal: Liver international Issue: Volume 36:Number 1(2016)Supplement Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗